Bivalirudin
Molecular Formula：
C98H138N24O33
Relative Molecular Mass：
2180.32 g/mol
CAS-Number：
128270-60-0 (net)
Long-term Storage：
-20 ± 5 °C
Synonyms：
BG 8967; Hirulog; Hirulog I
Sequence：
H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH trifluoroacetate salt
Fields of Application：
Moderate to high risk acute coronary syndromes
Percutaneous coronary intervention
Active Substance：
Bivalirudin is a synthetic hirudin analog. Bivalirudin acts as a specific and reversible direct thrombin inhibitor.
Company Profile:
company name:Shenzhen JYMed Technology Co.,Ltd.
Year Established:2009
Capital: 89.5 Million RMB
Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,GlucagonAcetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,.....
We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot
of ANDA peptide APIs and formulated products with CFDA and have fourty patents approved.
Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.
【More information Contact with: Yancey】
Skype：yancey.yang
Tel.+8615013529272 (whatsapp)
Email:yancey@jymedtech.cn
|
Pharma Sources Insight June 2024: Globalization on the Go
